Apotheek DE Scheerder SRL
The score of Apotheek DE Scheerder shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +61 % Total assets +81 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apotheek DE Scheerder's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 14,141 € | ||||
| Equity | 74,296 € | ||||
| Cash | 48,212 € | ||||
| EBITDA | 23,074 € | ||||
| Total assets | 128,527 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
- Year ended 31 Dec 2024filed on 21 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 18 Aug 2023
- Year ended 31 Dec 2021filed on 30 Aug 2022
Apotheek DE Scheerder's financial analysis
- Solvency57.8%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apotheek DE Scheerder
Apotheek DE Scheerder's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0889.330.741
- VAT number
- BE0889330741
- Peppol
- Registered · 0208:0889330741 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 May 2007
- Registered office
- 9000 Ghent
- Latest accounts
- 2025 · filed on 28 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apotheek DE Scheerder (SRL) has been based in Ghent since 2007, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 14,141 € and equity of 74,296 €; its revenue is not published. Its solvency stands at 57.8%, above the median of its sector (44.2%).
Companies similar to Apotheek DE Scheerder
Companies in the same business, of comparable size and area, outside its group.
- Montpharma Retail sale of pharmaceutical products Forest · balance sheet 135,487 €
- Pharmacie Severin Retail sale of pharmaceutical products Sambreville · balance sheet 243,411 €
- Eyeland Optics Retail sale of medical and orthopaedic goods Antwerp · balance sheet 150,587 €
- Phardep Retail sale of pharmaceutical products Ottignies-Louvain-la-Neuve · balance sheet 117,517 €
- Mega Pharma Retail sale of pharmaceutical products Merchtem · balance sheet 150,288 €
- Somad Retail sale of pharmaceutical products Frameries · balance sheet 170,686 €
- Sivahe Retail sale of pharmaceutical products Hasselt · balance sheet 172,297 €
- Jeûne & Hormèse Retail sale of pharmaceutical products Chaudfontaine · balance sheet 27,054 €
Frequently asked questions about Apotheek DE Scheerder
What is the revenue of Apotheek DE Scheerder?
Apotheek DE Scheerder files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apotheek DE Scheerder?
In Belgium, the VAT number is the company number prefixed with BE: BE0889330741 for Apotheek DE Scheerder, if the company is VAT-registered. Its company number (CBE) is 0889.330.741.
Where is the registered office of Apotheek DE Scheerder?
According to the CBE register, the registered office of Apotheek DE Scheerder is in 9000 Ghent.
What is the equity of Apotheek DE Scheerder?
At the close of the 2025 financial year, the equity of Apotheek DE Scheerder amounts to 74,296 €, a solvency of 57.8% of total assets.
Who manages Apotheek DE Scheerder?
The register lists 1 active mandates at Apotheek DE Scheerder. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apotheek DE Scheerder
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →